Therapeutics News
-
Empowering Lives: Rare Disease Diagnostics and Awareness
Therapeutics | Analysis | 1 Comment | 07 Feb, 2024
Rare diseases, often overlooked, affect a significant portion of the global population. However, early detection and int...Read more
-
Sysmex and Hitachi High-Tech to collaboratively develop New Genetic Testing Systems
Therapeutics | News | 0 Comment | 08 Feb, 2024
Sysmex Corporation and Hitachi High-Tech Corporation are collaborating to develop novel genetic testing systems based on...Read more
-
AstraZeneca expands US manufacturing footprint to accelerate next-gen cell therapy development
Therapeutics | News | 0 Comment | 07 Feb, 2024
AstraZeneca is investing $300 million in a state-of-the-art facility in Rockville, MD to launch its life-saving cell the...Read more
-
Australian government invests $20 M to find new therapies for childhood brain cancers
Therapeutics | News | 0 Comment | 05 Feb, 2024
The Australian government is funding a wide-ranging national research programme that will give new hope and help to Aust...Read more
-
Singapore develops new and precise way to treat most common type of brain cancer
Therapeutics | News | 0 Comment | 02 Feb, 2024
Researchers led by Nanyang Technological University, Singapore (NTU Singapore) have developed a new and precise way to t...Read more
-
Experts advocate HPV Vaccination Programmes for Gynaecologic Cancer prevention in MENA region
Therapeutics | Opinion | 0 Comment | 30 Jan, 2024
The 16th Obstetrics and Gynaecology Conference took place on 30 January under the theme ‘From evidence to practice...Read more
-
Breakthroughs in Rare Diseases Therapeutics
Therapeutics | Analysis | By Anusha Ashwin | 2 Comment | 01 Feb, 2024
The previous year witnessed many promising developments in the fight against rare diseases. The recent Casgevy’s F...Read more
-
Trailblazing Impact of Antibody-Drug Conjugates
Therapeutics | Opinion | By Joe Daccache, Project Leader, DeciBio | 1 Comment | 01 Feb, 2024
The field of Antibody-Drug Conjugates (ADCs) has experienced a remarkable transformation, shifting from dormancy to a su...Read more
-
Next-Gen ADCs as Precision Weapon Against Cancer
Therapeutics | Analysis | By Ayesha Siddiqui | 2 Comment | 01 Feb, 2024
Cancer poses a significant challenge for the pharmaceutical industry, driving a constant search for improved oncology dr...Read more
-
Study in Hong Kong sparks new therapeutic target for lung cancer
Therapeutics | News | 0 Comment | 30 Jan, 2024
Lung cancer is the leading cause of cancer deaths in Hong Kong and worldwide, but there is still an unmet clinical need ...Read more
-
AbbVie expands Biologics Manufacturing Capacity with $223 M investment at Singapore Site
Therapeutics | Company results | 4 Comment | 25 Jan, 2024
AbbVie expanded its Singapore manufacturing facility on 25th Jan, strengthening its manufacturing capabilities. With a n...Read more
-
New approaches to treat diverse bile duct cancers prevalent in Southeast Asia
Therapeutics | News | 0 Comment | 24 Jan, 2024
An international study led by the National Cancer Centre Singapore (NCCS) and Duke-NUS Medical School has effectively ta...Read more
-
Singapore paves way for therapies to maintain mental well-being of ageing individual
Therapeutics | News | 0 Comment | 22 Jan, 2024
A team of scientists from Nanyang Technological University, Singapore (NTU Singapore) has demonstrated that commun...Read more
-
Molecular Diagnostics may offer Hope for Cancer Drug Shortages in Asia
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 19 Jan, 2024
Projections by the International Agency for Research on Cancer estimate 15.1 million new cases per year, until 2040. Thi...Read more
-
Saudi Arabia approves first CRISPR/Cas9 gene-edited therapy for treatment of sickle cell disease
Therapeutics | News | 0 Comment | 12 Jan, 2024
US-based Vertex Pharmaceuticals Incorporated has announced that the Saudi Food and Drug Authority (SFDA) has g...Read more
-
Chinese medicine drug for myofibrillar myopathy receives orphan drug designation by US FDA
Therapeutics | News | 1 Comment | 12 Jan, 2024
The Centre for Chinese Herbal Medicine Drug Development of Hong Kong Baptist University (HKBU) has develo...Read more
-
Novel CAR T-cell therapy regimen to augment oncology care for hard-to-treat cancers
Therapeutics | Opinion | By Hithaishi C Bhaskar | 0 Comment | 11 Jan, 2024
Kite Pharma, a Gilead Company, is a global biopharmaceutical company specializing in cancer cell therapy As the global c...Read more
-
Therapeutics | Company results | By Hithaishi C Bhaskar | 5 Comment | 09 Jan, 2024
GYSS 2024 is celebrating the values of science promoting collaboration and teamwork in Singapore from 8 to 12 January 20...Read more
